0000914475-14-000096.txt : 20141219
0000914475-14-000096.hdr.sgml : 20141219
20141219143254
ACCESSION NUMBER: 0000914475-14-000096
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141217
FILED AS OF DATE: 20141219
DATE AS OF CHANGE: 20141219
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC
CENTRAL INDEX KEY: 0000914475
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330525145
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 617-7600
MAIL ADDRESS:
STREET 1: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gano Kyle
CENTRAL INDEX KEY: 0001567160
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-22705
FILM NUMBER: 141298841
MAIL ADDRESS:
STREET 1: NEUROCRINE BIOSCIENCES, INC.
STREET 2: 12780 EL CAMINO REAL
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2014-12-17
0000914475
NEUROCRINE BIOSCIENCES INC
NBIX
0001567160
Gano Kyle
NEUROCRINE BIOSCIENCES, INC.
12780 EL CAMINO REAL
SAN DIEGO
CA
92130
0
1
0
0
Chief Business Dev Officer
Common Stock
2014-12-17
4
M
0
4957
5.00
A
28695
D
Common Stock
2014-12-17
4
S
0
4957
22.50
D
23738
D
Incentive Stock Option
5.00
2014-12-17
4
M
0
4957
5.00
D
2015-03-12
Common Stock
4957
0
D
The option was granted March 12, 2008 and vested in 36 equal monthly installments beginning April 12, 2008.
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
Timothy P. Coughlin, By Power of Attorney
2014-12-19